Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5214052 | SANDOZ | Method for dissolving arginineamides and pharmaceutical compositions containing them |
Jun, 2014
(9 years ago) |
Market Authorisation Date: 30 June, 2000
Treatment: NA
Dosage: INJECTABLE;INJECTION
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7687516 | CIPLA | Alcohol free formulation of argatroban |
Sep, 2027
(3 years from now) | |
US7589106 | CIPLA | Alcohol free formulation of argatroban |
Sep, 2027
(3 years from now) |
Market Authorisation Date: 29 June, 2011
Treatment: Method of treating an argatroban treatable condition; Method of treating thrombosis
Dosage: INJECTABLE;INTRAVENOUS